AT403160B - PROCESS FOR THE PREPARATION OF PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE - Google Patents

PROCESS FOR THE PREPARATION OF PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE Download PDF

Info

Publication number
AT403160B
AT403160B AT0900494A AT900494A AT403160B AT 403160 B AT403160 B AT 403160B AT 0900494 A AT0900494 A AT 0900494A AT 900494 A AT900494 A AT 900494A AT 403160 B AT403160 B AT 403160B
Authority
AT
Austria
Prior art keywords
oxo
pyridoxine
preparation
pyrrolidone carboxylate
isopropanol
Prior art date
Application number
AT0900494A
Other languages
German (de)
Other versions
ATA900494A (en
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of ATA900494A publication Critical patent/ATA900494A/en
Application granted granted Critical
Publication of AT403160B publication Critical patent/AT403160B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)

Description

AT 403 160 BAT 403 160 B

Die vorliegende Erfindung bezieht sich auf ein Verfahren zur Herstellung von Pyridoxin 5-Oxo-2-pyrrolidoncarboxylat, welches die folgende Formel aufweist:The present invention relates to a process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate, which has the following formula:

Pyridoxin 5-Oxo-2-pyrrolidoncarboxylat ist eine bekannte Substanz, welche seit vielen Jahren für therapeutische Zwecke verwendet wird.Pyridoxine 5-oxo-2-pyrrolidone carboxylate is a known substance which has been used for therapeutic purposes for many years.

Pyridoxin, welches auch als Vitamin B6 bekannt ist, ist ein gut bekanntes Wirkprinzip, welches unter anderen Verwendung in der Behandlung von akuten, alkoholischen Intoxikationen gefunden hat, obwohl bestimmte Verwirrungen in bezug auf seine reelle, positive Wirkung in therapeutischen Behandlungen auftraten. ES wurde in der Folge gefunden, und dies ist der Gegenstand des Italienischen Patentes Nr. 1.131.856, daß das Salz von Pyridoxin mit Pyrrolidoncarbonsäure ehe effiziente, therapeutische Wirkung bei der Behandlung von akuten, alkoholischen Intoxikationen zeigt.Pyridoxine, also known as vitamin B6, is a well-known principle of action that has found other uses in the treatment of acute alcoholic intoxications, although certain confusion has arisen regarding its real, positive effects in therapeutic treatments. It was subsequently found, and this is the subject of Italian Patent No. 1,131,856, that the salt of pyridoxine with pyrrolidonecarboxylic acid shows efficient therapeutic effects in the treatment of acute alcoholic intoxications.

Unter anderen Symptomatologien, welche effizient mit der Verbindung, welche gemäß der Erfindung herstellbar sind behandelt werden können, sind auch Erbrechenszustände und jene von Hyperprolaktinä-mien, welche durch Neuroendokrinstörungen aus iatrogenem Ursprung induziert werden, bemerkenswert.Among other symptomatologies that can be treated efficiently with the compound that can be prepared according to the invention, vomiting conditions and those of hyperprolactinias induced by iatrogenic neuroendocrine disorders are also noteworthy.

Eine einfache industrielle Herstellung dieser Verbindung mit guten Ausbeuten erscheint daher wichtig zu sein. Bis dato hat sich die Herstellung dieser Verbindung selbst eines Verfahrens (Italienisches Patent Nr. 1.131.855) bedient, das die Reaktion unter Hitze und Rühren für 30 min von Lösungen vorzugsweise in Ethanol von Pyridoxin und Pyroglutaminsäure, das anschließende Fällen durch Kühlen des rohen Reaktionsproduktes ausnützt. Das letztere letztere wurde dann einer Reinigung durch Chromatographie auf eine lonenaustauscherharz unterworfen, wobei schließlich das gewünschte Produkt durch Ausfällen des Rückstandes, welcher mit Hilfe des Abdampfens unter verringertem Druck des Eluates erhalten wurde, isoliert wurde.A simple industrial production of this compound with good yields therefore appears to be important. To date, the preparation of this compound has itself used a process (Italian Patent No. 1,131,855) which involves the reaction under heat and stirring for 30 min of solutions, preferably in ethanol of pyridoxine and pyroglutamic acid, followed by precipitation by cooling the crude reaction product takes advantage of. The latter the latter was then subjected to purification by chromatography on an ion exchange resin, finally isolating the desired product by precipitating the residue obtained by evaporation under reduced pressure of the eluate.

Der Hauptgegenstand der vorliegenden Erfindung ist es, ein Verfahren zur Herstellung des Hauptproduktes zur Verfügung zu stellen, welches sich als industriell vorteilhaft erweisen sollte, und zwar sowohl in bezug auf den Standpunkt der Ausbeute als auch auf das einfache Herstellungsverfahren.The main object of the present invention is to provide a process for the production of the main product which should prove to be industrially advantageous in terms of both the yield point of view and the simple production process.

Zu diesem Zweck stellt die vorliegende Erfindung ein Verfahren zur Herstellung von Pyridoxin 5-Oxo-2-pyrrolidoncarboxylat, welches die folgende Formel aufweist:For this purpose, the present invention provides a process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate, which has the following formula:

22nd

AT 403 160 B zur Verfügung, welches dadurch gekennzeichnet ist, daß äquimolekulare Mengen von Pyridoxinbase und Pyroglutaminsäure als feste Pulver, welche sorgfältig vermischt sind und mit einer geringen Menge an 5-10 % deionisiertes Wasser enthaltendem Isopropanol versetzt sind, umgesetzt werden.AT 403 160 B is available, which is characterized in that equimolecular amounts of pyridoxine base and pyroglutamic acid are reacted as solid powders, which are mixed thoroughly and mixed with a small amount of 5-10% deionized water containing isopropanol.

Das Produkt, welches sich langsam in dem kristallinen Zustand bildet, wird granuliert, getrocknet und schließlich aus warme Isopropanol kristallisiert.The product, which slowly forms in the crystalline state, is granulated, dried and finally crystallized from warm isopropanol.

Die hievon erhaltene Salzform wird durch den Schmelzpunkt und durch das I.R.-Spektrum, welches charakteristische Absorptionsbanden des Salzes zeigt, welche unterschiedlich von jenen der zwei Ausgangprodukte sind, bestätigt.The salt form obtained therefrom is confirmed by the melting point and by the I.R. spectrum, which shows characteristic absorption bands of the salt which are different from those of the two starting products.

Das DSC-Spektrum bestätigt die Bildung des gewünschten Salzes.The DSC spectrum confirms the formation of the desired salt.

Das erhaltene Salz hat ein Molekulargewicht von 298,28 und die folgende Zusammensetzung in Prozent: C: 52 %, H: 6,08 %, N: 9,33 % und 0: 32,18 % und hat das Aussehen eines weißen, geruchlosen, kristallinen Pulvers, welches einen Schmelzpunkt von 96 bis 98 * C aufweist und welches einen geringfügig sauren Geschmack hat, stark wasserlöslch ist, wenig in kalten Ethanol löslich ist und in üblichen organischen Lösungsmitteln, wie Aceton, Ethylester, Chloroform und Benzol, unlöslich ist.The salt obtained has a molecular weight of 298.28 and the following composition in percent: C: 52%, H: 6.08%, N: 9.33% and 0: 32.18% and has the appearance of a white, odorless , crystalline powder, which has a melting point of 96 to 98 ° C and which has a slightly acid taste, is highly water-soluble, is poorly soluble in cold ethanol and is insoluble in conventional organic solvents such as acetone, ethyl ester, chloroform and benzene.

Aus der vorherigen Beschreibung ebenso wie aus dem erläuternden Beispiel, weiches folgt, wird es klar verständlich sein, daß das Verfahren gemäß der vorliegenden Erfindung die zuvor angeführten Zwecke erreicht und daher ein hohes industrielles Interesse mit sich bringt.From the foregoing description, as well as from the illustrative example that follows, it will be clearly understood that the method according to the present invention achieves the purposes set out above and therefore has a high level of industrial interest.

BEISPIEL 8,663 kg 1,2-Pyrrolidon-5-carbonsäure und 1,337 kg Pyridoxinbase werden sorgfältig gesiebt und 30 min vermischt.EXAMPLE 8.663 kg of 1,2-pyrrolidone-5-carboxylic acid and 1.337 kg of pyridoxine base are carefully sieved and mixed for 30 minutes.

Zu der resultierenden Mischung werden 9 I einer Lösung von Isopropanol, welches 400 ml deionisiertes Wasser enthält, zugesetzt, wobei die Lösung auf 35 * C gehalten wird.9 l of a solution of isopropanol containing 400 ml of deionized water are added to the resulting mixture, the solution being kept at 35 ° C.

Nachdem 10 min gerührt wurde, wird eine Paste erhalten, welche sind langsam verfestigt.After stirring for 10 minutes, a paste is obtained, which are slowly solidified.

Die kristalline Masse, welche hieraus entsteht, wird granuliert und im Vakuum bei 38 *C für 24 Std. gtrocknet.The crystalline mass resulting from this is granulated and dried in vacuo at 38 * C for 24 hours.

Der resultierende Feststoff (18,6 kg, 93 % Ausbeute) wird in etwa 40 I siedendem Isopropanol gelöst, bei 40 * C kristallisieren gelassen und schließlich filtriert und bei 38 · C für weitere 24 Std. getrocknet, was die folgenden, analytischen Daten ergeben:The resulting solid (18.6 kg, 93% yield) is dissolved in about 40 l of boiling isopropanol, allowed to crystallize at 40 ° C. and finally filtered and dried at 38 ° C. for a further 24 hours, which gives the following analytical data :

Schmelzpunkt: 98- 100 “C NMR: (in D20) wie in Fig. 1 DSC: wie in Fig. 2 IR: wie in Fig. 3 TABELLE 2Melting point: 98-100 “C NMR: (in D20) as in FIG. 1 DSC: as in FIG. 2 IR: as in FIG. 3 TABLE 2

AnalysenparameterAnalysis parameters

Ausgangstemperatur *C 60 Variation K/min 10 Endtemperatur *C 160 ISO-Zeit min 0 Diagramm cm 10 FS-Bereich mW 20 Schwankungen % 90 Typen von Platten 1/2 2 mW-Limit 0 Sieb DYN/ISO 1/2 0 Identifikationsnummer 1 Gewicht in mg 5,4Initial temperature * C 60 variation K / min 10 final temperature * C 160 ISO time min 0 diagram cm 10 FS range mW 20 fluctuations% 90 types of plates 1/2 2 mW limit 0 sieve DYN / ISO 1/2 0 identification number 1 Weight in mg 5.4

Das obige Beispiel hat offensichtlich hauptsächlich illustrativen und nicht beschränkenden Charakter, so daß Änderungen und Variationen, welche im Konzept äquivalent sind, möglich sind und vorhersehbar 3The above example is obviously primarily illustrative and not restrictive, so that changes and variations that are conceptually equivalent are possible and predictable 3

Claims (3)

AT 403 160 B immer noch in den Grenzen dieser Erfindung verbleiben. Patentansprüche 1. Verfahren zur Herstellung von Pyridoxin 5-Oxo-2-pyrrolidoncarboxylat, welches die folgende Formel aufweist: H «AT 403 160 B still remain within the limits of this invention. 1. Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate, which has the following formula: CH2OH CH3 ----\ + / N 1 H dadurch gekennzeichnet, daß äquimolekulare Mengen von Pyridoxinbase und Pyroglutaminsäure als feste Pulver, welche sorgfältig vermischt sind und mit einer geringen Menge an 5-10 % deionisiertes Wasser enthaltendem Isopropanol versetzt sind, umgesetzt werden.CH2OH CH3 ---- \ + / N 1 H, characterized in that equimolecular amounts of pyridoxine base and pyroglutamic acid are reacted as solid powders, which are carefully mixed and mixed with a small amount of 5-10% deionized water containing isopropanol. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß das in Form einer Paste vorliegende Reaktionsprodukt so lange stehen gelassen wird, bis ein kristalliner Feststoff gebildet wird, welcher granuliert und unter Hitze vakuumgetrocknet wird.2. The method according to claim 1, characterized in that the reaction product in the form of a paste is allowed to stand until a crystalline solid is formed, which is granulated and vacuum-dried under heat. 3. Verfahren nach Anspruch 1, dadurch gekennzeichnet daß die Reinigung durch Kristallisation aus Isopropanol durchgeführt wird. Hiezu 3 Blatt Zeichnungen 43. The method according to claim 1, characterized in that the cleaning is carried out by crystallization from isopropanol. Including 3 sheets of drawings 4
AT0900494A 1993-02-23 1994-02-19 PROCESS FOR THE PREPARATION OF PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AT403160B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930340A IT1263956B (en) 1993-02-23 1993-02-23 PROCEDURE FOR THE PREPARATION OF 5-OXO-2-PYROLIDONCARBOSSILATE OF PYRIDOXY

Publications (2)

Publication Number Publication Date
ATA900494A ATA900494A (en) 1997-04-15
AT403160B true AT403160B (en) 1997-11-25

Family

ID=11365118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0900494A AT403160B (en) 1993-02-23 1994-02-19 PROCESS FOR THE PREPARATION OF PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE

Country Status (5)

Country Link
KR (1) KR100257967B1 (en)
AT (1) AT403160B (en)
IT (1) IT1263956B (en)
TW (1) TW235962B (en)
WO (1) WO1994019324A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105906559B (en) * 2016-06-14 2018-08-14 成都倍特药业有限公司 A kind of one-step synthesis of pharmaceutical grade metadoxine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313952A (en) * 1980-06-30 1982-02-02 Massimo Baldacci Method of treating acute alcoholic intoxication with pyridoxine P.C.A.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6990M (en) * 1968-03-13 1969-05-27
FR2244466A1 (en) * 1973-06-29 1975-04-18 Dufour Claude Salts of pyridoxine with aryloxy alkanoic acids - useful as antihyperlipemic agents for oral administration
FR2260330A1 (en) * 1974-02-07 1975-09-05 Innothera Lab Sa Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
FR2485372B1 (en) * 1980-06-30 1985-08-09 Baldacci Lab Spa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313952A (en) * 1980-06-30 1982-02-02 Massimo Baldacci Method of treating acute alcoholic intoxication with pyridoxine P.C.A.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GARAU ET AL.: METADOXINE, ALCOHOL ALCOHOL, 1992, 27(5) SEITEN 501 - 504 (CHEM. ABSTR. 118: 139258P) *

Also Published As

Publication number Publication date
KR100257967B1 (en) 2000-07-01
IT1263956B (en) 1996-09-05
KR940019703A (en) 1994-09-14
ITMI930340A1 (en) 1994-08-23
WO1994019324A1 (en) 1994-09-01
ITMI930340A0 (en) 1993-02-23
TW235962B (en) 1994-12-11
ATA900494A (en) 1997-04-15

Similar Documents

Publication Publication Date Title
DE3820166C2 (en) 4-hydroxy-4- (indol-3-ylmethyl) glutamic acid, its inner lactone and lactam, processes for their preparation and their use as or in sweeteners
DE2902438C2 (en)
DE2147023C3 (en) Process for the preparation of 1H-tetrazole compounds
EP0977736B1 (en) Process for preparing pure flupirtin maleate and its modification a
DE2824116C2 (en)
DE60123125T2 (en) PROCESS FOR THE PREPARATION OF 1- (AMINOMETHYL) CYCLOHEXANIC ACID
AT403160B (en) PROCESS FOR THE PREPARATION OF PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE
DE2656602C3 (en) Method for extracting 2-hydroxymethyl-3,4,5-trihydroxypiperidine from mulberry plants
DE2000030C3 (en) 3-alkoxy- and 3-phenoxy-2- (diphenylhydroxy) methyl-propylamines and medicaments containing them
DE830994C (en) Process for the production of double salts of streptomycin
DE2614115A1 (en) ECHINATINE GLYCOSIDES AND THE METHOD OF MANUFACTURING THEREOF
DE3807595A1 (en) OPTICALLY ACTIVE OXO-ISOINDOLINYL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE3246135C2 (en) Crystalline gamma-bestatin and process for its preparation
DE902300C (en) Process for the preparation of a therapeutically active 17-oxycorticosterone ester
DE964238C (en) Process for the preparation of pure oxytetracycline compounds
DE2605650A1 (en) PROCESS FOR THE PRODUCTION OF PARA-ISOBUTYL-PHENYL ACID DERIVATIVES
DE1045392B (en) Process for the preparation of pure compounds of tetracycline
DE3500029A1 (en) Anthracycline esters
DE2148959C3 (en) Process for the preparation of N-substituted 4-anilinopiperidines
DE933450C (en) Process for the preparation of a new salt of penicillin G.
DE1620479C3 (en) Xylitol pentanicotinate and its acid addition salts
DE611158C (en) Process for the production of hexamethylenetetramine betaine
DE2024805C3 (en) Process for the preparation of 2-amino-3-chloropyrazine
DE2422879C3 (en) Process for the preparation of l- (2-hydroxy-2-indanyl) propylamine
DE629952C (en) Process for the preparation of salts from bases and acidic guaiacol phosphoric acid esters

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee